Valneva SE (EPA:VLA)
France · Delayed Price · Currency is EUR 3.696
-0.088 (-2.33%)
Sep 5, 2025, 5:35 PM CET
Valneva SE Market Cap
Valneva SE has a market cap or net worth of €634.72 million as of September 5, 2025. Its market cap has increased by 39.66% in one year.
Market Cap
634.72M
Enterprise Value
670.33M
Revenue
196.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.70
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 99.08M to 634.72M, an increase of 540.62%. That is a compound annual growth rate of 10.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 634.72M | 80.78% |
| Dec 31, 2024 | 351.10M | -46.40% |
| Dec 29, 2023 | 655.08M | -23.93% |
| Dec 30, 2022 | 861.12M | -66.55% |
| Dec 31, 2021 | 2.57B | 265.20% |
| Dec 31, 2020 | 704.92M | 201.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 119.71B |
| Sanofi | 96.95B |
| Sartorius Stedim Biotech | 16.91B |
| bioMérieux | 13.95B |
| Eurofins Scientific SE | 11.34B |
| Ipsen | 9.88B |
| ABIVAX Société Anonyme | 5.78B |
| Virbac | 2.71B |